Insider Transactions last 24 months for Zentalis Pharmaceuticals, Inc.  -  NSDQ: ZNTL

 
Transactions
All Buy Sell Option Exercise
Filer's Name
Relationship/
Title
Trans.
Date
Trans. Type
Ownership Type
Security Type
Shares
Price
Trans.
Value
Total Shares Owned
Vultaggio VincentPAO and PFO02/10/2026DSDirectCOM6,894$2.42$16,699.34146,506
Eastland Julia MarieCEO & President02/09/2026DSDirectCOM889$2.39$2,127.2979,133
Bruns IngmarChief Medical Officer02/09/2026DSDirectCOM335$2.39$801.6233,332
Vultaggio VincentPAO and PFO02/09/2026DSDirectCOM3,379$2.39$8,085.61153,400
Eastland Julia MarieCEO & President02/06/2026DSDirectCOM7,866$2.43$19,112.0280,022
Bruns IngmarChief Medical Officer02/06/2026DSDirectCOM2,962$2.43$7,196.7733,667
Vultaggio VincentPAO and PFO02/06/2026DSDirectCOM29,951$2.43$72,771.94156,779
Vultaggio VincentPAO and PFO02/03/2026DSDirectCOM556$2.52$1,398.34186,730
Vultaggio VincentPAO and PFO02/02/2026DSDirectCOM2,540$2.55$6,477.00187,286
Walters GroupOther12/31/2025APDirectCOM6,459,973$1.20$7,751,967.6013,509,973
Matrix Capital Management Company, LpOther12/15/2025DSIndirectCOM7,500,000$1.33$9,975,000.006,459,973
Myers Scott DunsethDirector06/17/2025AADirectCOM57,603$0.00$0.00338,795
Kariuki EnochDirector06/17/2025AADirectCOM57,603$0.00$0.00137,365
Johnson David MichaelDirector06/17/2025AADirectCOM57,603$0.00$0.00250,421
Skvarka JanDirector06/17/2025AADirectCOM57,603$0.00$0.00207,154
Walker Luke NathanielDirector06/17/2025AADirectCOM57,603$0.00$0.00144,284
Myers Scott DunsethDirector04/30/2025APDirectCOM21,000$1.40$29,372.70281,192
Bruns IngmarChief Medical Officer02/06/2025APDirectCOM20,000$2.28$45,656.0036,629
Eastland Julia MarieCEO & President02/03/2025AADirectCOM59,388$0.00$0.0087,888
Bruns IngmarChief Medical Officer02/03/2025AADirectCOM16,629$0.00$0.0016,629
Paul AndreaChief Legal Officer02/03/2025DSDirectCOM13,230$1.71$22,643.151,070,784
Paul AndreaChief Legal Officer02/03/2025AADirectCOM934,041$0.00$0.001,084,014
Lackner MarkChief Scientific Officer02/03/2025DSDirectCOM14,368$1.71$24,590.83512,856
Lackner MarkChief Scientific Officer02/03/2025AADirectCOM335,907$0.00$0.00527,224
Vultaggio VincentPAO and Interim PFO02/03/2025DSDirectCOM2,615$1.71$4,475.57189,826
1   2  Next Last  You are at page 1 of 2 pages
Transaction Type Key
First letter: A = Acquired, D = Disposed
Second letter:
A = Grant, award or other acquisition pursuant to Rule 16b-3(d) C = Conversion of derivative security | D = Disposition to the issuer of issuer equity securities pursuant to Rule 16b-3(e) | E = Expiration of short derivative position | F = Payment of exercise price or tax liability by delivering or withholding securities incident to the receipt, exercise or vesting of a security issued in accordance with Rule 16b-3. | G = Gift | H = Expiration (or cancellation) of long derivative position with value received | I = Discretionary transaction in accordance with Rule 16b-3(f) | J = Other | L = Small acquisition under Rule 16a-6 | M = Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 | O = Exercise of out-of-the-money derivative security | P = Open market or private purchase | S = Open market or private sale | U = Disposition pursuant to a tender of shares in a change of control transaction | W = Acquisition or disposition by will or the laws of descent and distribution | X = Exercise of in-the-money or at-the-money derivative security | Z = Deposit into or withdrawal from voting trust
Export Table Data to Excel Send to Excel